Atlas Trials

D-serine for the Schizophrenia Prodrome

Clinical trial NCT00826202 · COMPLETED

Trial details

NCT number
NCT00826202
Sponsor
Nathan Kline Institute for Psychiatric Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia Prodrome
Start date
2009-03-01
Primary completion
2012-11-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.